Tranzyme
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Tranzyme sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Tranzyme: 8 sponsored US clinical trials, none currently recruiting.
Tranzyme sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gastrointestinal Dysmotility, with 1 trials.
Upper-quartile sponsor footprint
Tranzyme sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
NCT01664637
Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
NCT01452815
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
NCT01316484
Ulimorelin Study of Efficacy and Safety (ULISES 008)
NCT01296620
Ulimorelin Study of Efficacy and Safety (ULISES 007)
NCT01285570
Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
NCT00889486
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
NCT00612014
Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
NCT00617552
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 5 |
| Phase 3 | 2 |
Therapeutic Areas
How the Tranzyme early-phase archive is shaped
8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).
Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Gastrointestinal Dysmotility (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Tranzyme: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Tranzyme sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Tranzyme page
8 registered trials is a research-attention snapshot, not an endorsement of Tranzyme or any single study.
- None of Tranzyme's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Gastrointestinal Dysmotility is the condition Tranzyme studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gastrointestinal Dysmotility trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tranzyme pipeline card: 8 registered trials from official public datasets.Report a data error.